LetterLetter
14-3-3η in “Seronegative” Rheumatoid Arthritis
STANLEY J. NAIDES and ANTHONY MAROTTA
The Journal of Rheumatology October 2015, 42 (10) 1995; DOI: https://doi.org/10.3899/jrheum.150330
STANLEY J. NAIDES
Medical Director, Immunology R&D, Quest Diagnostics Nichols Institute, San Juan Capistrano, California,
USA;
MD, FACP, FACRANTHONY MAROTTA
Chief Scientific Officer, Augurex Life Sciences Corp., North Vancouver, British Columbia,
Canada.
PhDREFERENCES
- 1.↵
- 2.↵
- Kilani RT,
- Maksymowych WP,
- Aitken A,
- Boire G,
- St-Pierre Y,
- Li Y,
- et al.
- 3.↵
- Maksymowych WP,
- Naides SJ,
- Bykerk V,
- Siminovitch KA,
- van Schaardenburg D,
- Boers M,
- et al.
In this issue
The Journal of Rheumatology
Vol. 42, Issue 10
1 Oct 2015
14-3-3η in “Seronegative” Rheumatoid Arthritis
STANLEY J. NAIDES, ANTHONY MAROTTA
The Journal of Rheumatology Oct 2015, 42 (10) 1995; DOI: 10.3899/jrheum.150330